ConductScience.org, home

Paper20002104

Evidence that the plant cannabinoid cannabigerol is a highly potent alpha2-adrenoceptor agonist and moderately potent 5HT1A receptor antagonist.

Cascio MG and 4 others. Br J Pharmacol, 2010. Cited by 186 papers, by iCite.

Cite this record

ConductScience Library. Evidence that the plant cannabinoid cannabigerol is a highly potent alpha2-adrenoceptor agonist and moderately potent 5HT1A receptor antagonist. Papers, record 20002104. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20002104

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Evidence that the plant cannabinoid cannabigerol is a highly potent alpha2-adrenoceptor agonist and moderately potent 5HT1A receptor antagonist.
PubMed
Journal
Br J Pharmacol
PubMed
Year
2010
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
186
iCite
Relative citation ratio, by iCite
6.01
iCite
Revised in PubMed
2025-05-29
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cascio MGM G
2Gauson LAL A
3Stevenson LAL A
4Ross RAR A
5Pertwee RGR G

Source PubMed

Download CSV of authors

Topics21

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adrenergic alpha-AgonistsMajor topic
CannabinoidsMajor topic
Serotonin 5-HT1 Receptor AntagonistsMajor topic
Serotonin AntagonistsMajor topic
Adrenergic alpha-2 Receptor Agonists
Animals
CHO Cells
Cannabis
Cricetinae
Cricetulus
Dose-Response Relationship, Drug
Humans
Male
Mice
Mice, Inbred C57BL
Mice, Knockout
Muscle Contraction
Protein Binding
Receptor, Cannabinoid, CB1
Receptor, Cannabinoid, CB2
Vas Deferens

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 DA003672NIDA NIH HHSUnited StatesR01DA003672PubMed and NIHNIH RePORTER
R37 DA003672NIDA NIH HHSUnited StatesR01DA003672PubMed and NIHNIH RePORTER
DA-03672NIDA NIH HHSUnited StatesR01DA003672PubMed and NIHNIH RePORTER
R37DA003672NIHNIH RePORTER

Download CSV of grants

References34

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
118354058Plant-derived cannabinoids modulate the activity of transient receptor potential channels of ankyrin type-1 and melastatin type-8.J Pharmacol Exp Ther2008https://conductscience.org/library/papers/18354058PubMed
29336020Pharmacology of cannabinoid CB1 and CB2 receptors.Pharmacol Ther1997https://conductscience.org/library/papers/9336020PubMed
317245363Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro.Br J Pharmacol2007https://conductscience.org/library/papers/17245363PubMed
410516656Structural determinants of the partial agonist-inverse agonist properties of 6'-azidohex-2'-yne-delta8-tetrahydrocannabinol at cannabinoid receptors.Br J Pharmacol1999https://conductscience.org/library/papers/10516656PubMed
51658999Noradrenaline-ATP co-transmission in the sympathetic nervous system.Trends Pharmacol Sci1991https://conductscience.org/library/papers/1658999PubMed
68566121A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635.Eur J Pharmacol1995https://conductscience.org/library/papers/8566121PubMed
7150333946"-Azidohex-2"-yne-cannabidiol: a potential neutral, competitive cannabinoid CB1 receptor antagonist.Eur J Pharmacol2004https://conductscience.org/library/papers/15033394PubMed
84987683Chemical basis of hashish activity.Science1970https://conductscience.org/library/papers/4987683PubMed
916199061Chemical constituents of marijuana: the complex mixture of natural cannabinoids.Life Sci2005https://conductscience.org/library/papers/16199061PubMed
1011683519Stimulation frequency-noradrenaline release relationships examined in alpha2A-, alpha2B- and alpha2C-adrenoceptor-deficient mice.Naunyn Schmiedebergs Arch Pharmacol2001https://conductscience.org/library/papers/11683519PubMed
118960884Agonist-antagonist characterization of 6'-cyanohex-2'-yne-delta 8-tetrahydrocannabinol in two isolated tissue preparations.Eur J Pharmacol1996https://conductscience.org/library/papers/8960884PubMed
124981896Psychopharmacological activity of the active constituents of hashish and some related cannabinoids.Psychopharmacologia1969https://conductscience.org/library/papers/4981896PubMed
1311520889Presynaptic autoreceptors in the third decade: focus on alpha2-adrenoceptors.J Neurochem2001https://conductscience.org/library/papers/11520889PubMed
1417828291The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin.Br J Pharmacol2008https://conductscience.org/library/papers/17828291PubMed
1517157480Cannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis.J Dermatol Sci2007https://conductscience.org/library/papers/17157480PubMed
1618680204Alpha2-agonists as analgesic agents.Med Res Rev2009https://conductscience.org/library/papers/18680204PubMed
1717019247Clonidine--a potent analgesic adjuvant.Curr Opin Anaesthesiol2002https://conductscience.org/library/papers/17019247PubMed
189374269[Gamma-35S]GTP autoradiography allows region-specific detection of muscarinic receptor-dependent G-protein activation in the chick optic tectum.Brain Res1997https://conductscience.org/library/papers/9374269PubMed
1911698100Modulation of transmitter release via presynaptic cannabinoid receptors.Trends Pharmacol Sci2001https://conductscience.org/library/papers/11698100PubMed
208666005Pharmacological characterization of three novel cannabinoid receptor agonists in the mouse isolated vas deferens.Eur J Pharmacol1995https://conductscience.org/library/papers/8666005PubMed

See all 34 referencesDownload CSV of references

Cited by129

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 186 citations.

PMIDTitleJournalYearIn PapersSource
42883319Cannabigerol Modulates Blood Pressure and Vascular Reactivity in a Rat Model of Hypertension and Platelet Responses in Human Blood In Vitro.Molecules2026https://conductscience.org/library/papers/42883319PubMed
42871546Cannabigerol Enhances Muscle Strength and Performance in Dexamethasone-Treated Mice.ACS Pharmacol Transl Sci2026https://conductscience.org/library/papers/42871546PubMed
42829479Optimal cannabinoid-terpene combination ratios suppress mutagenicity of gastric reflux in normal and metaplastic esophageal cells.World J Gastroenterol2026https://conductscience.org/library/papers/42829479PubMed
42793092Cannabinoids in Cancer: Molecular Mechanisms of Tumor Cell Death and Translational Opportunities.Biomolecules2026https://conductscience.org/library/papers/42793092PubMed
42783432Cannabigerol at the Interface of the Gut Microbiota and EndoCannabinoidome: Mechanistic Insights into Inflammation and Pain Modulation.Med Sci (Basel)2026https://conductscience.org/library/papers/42783432PubMed
42744343The anterior cingulate cortex mediates cisplatin-induced mechanical allodynia and represents a target for cannabigerol antinociception.Mol Pain2026https://conductscience.org/library/papers/42744343PubMed
42653723Pharmacological Switching in Minor Phytocannabinoids: A Mechanistic Framework for Compound-Indication Matching and Precision Neurotherapeutic Development.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42653723PubMed
42394854Concomitant activation of D1 dopamine and α2A adrenergic receptors improves cognition better than methylphenidate in two rodent behavioral tests.Discov Pharm Sci2026https://conductscience.org/library/papers/42394854PubMed
42139799Minor cannabinoids CBD, CBG, CBN, and CBC differentially modulate sensory neuron activation.J Pharmacol Exp Ther2026https://conductscience.org/library/papers/42139799PubMed
42121212Cannabidiol and other non-psychotropic cannabinoids from Cannabis sativa as therapeutics for microglial-mediated neuroinflammation and neurodegeneration.J Cannabis Res2026https://conductscience.org/library/papers/42121212PubMed
41919226Elucidating the putative role of cannabigerol: a hypothesis-generating review of neuroinflammatory and neuroprotective mechanisms with implications for drug-resistant epilepsy.Front Pharmacol2026https://conductscience.org/library/papers/41919226PubMed
41794091Cannabichromene attenuates fracture pain but impairs bone repair in a murine tibial fracture model.Bone2026https://conductscience.org/library/papers/41794091PubMed
41646286Concomitant activation of D1 dopamine and α2A adrenergic receptors improves cognition compared with methylphenidate.Res Sq2026https://conductscience.org/library/papers/41646286PubMed
41446792Pharmacokinetics and pharmacodynamics of cannabigerol (CBG) in the C57BL/6Crl mouse.Front Pharmacol2025https://conductscience.org/library/papers/41446792PubMed
41423277Cannabigerol Exerts In Vivo and In Vitro Anti-Inflammatory Effects via Inhibition of the MAPK and NF-κB Pathways.J Microbiol Biotechnol2025https://conductscience.org/library/papers/41423277PubMed
41234397Metabolism, pharmacokinetics, and bioavailability of cannabigerol in horses following intravenous and oral administration with micellar and oil formulations.Front Vet Sci2025https://conductscience.org/library/papers/41234397PubMed
41155621Cannabigerol Modulates Cannabinoid Receptor Type 2 Expression in the Spinal Dorsal Horn and Attenuates Neuropathic Pain Models.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/41155621PubMed
41068546The Pharmacological Profile of Plant-Derived Cannabinoids In Vitro.Curr Top Behav Neurosci2026https://conductscience.org/library/papers/41068546PubMed
40917785Analgesic and toxicological evaluation of cannabidiol-rich Moroccan Cannabis sativa L. (Khardala variety) extract: Evidence from an in vivo and in silico study.Open Life Sci2025https://conductscience.org/library/papers/40917785PubMed
40869376Cannabigerol Attenuates Memory Impairments, Neurodegeneration, and Neuroinflammation Caused by Transient Global Cerebral Ischemia in Mice.Int J Mol Sci2025https://conductscience.org/library/papers/40869376PubMed

See all 129 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ADRA2B151PubTator's text mininghttps://conductscience.org/library/genes/151NCBI Gene
CNR11268PubTator's text mininghttps://conductscience.org/library/genes/1268NCBI Gene
HTR1A3350PubTator's text mininghttps://conductscience.org/library/genes/3350NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20002104

GET https://conductscience.org/api/papers/v1/20002104/references?page=2